| 000 | 01285 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517191758.0 | ||
| 264 | 0 | _c20180716 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1999-4915 | ||
| 024 | 7 |
_a10.3390/v9120382 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAngelova, Assia L | |
| 245 | 0 | 0 |
_aImmunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity. _h[electronic resource] |
| 260 |
_bViruses _c12 2017 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aGlioblastoma _xtherapy |
| 650 | 0 | 4 |
_aH-1 parvovirus _xgrowth & development |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunologic Factors |
| 650 | 0 | 4 |
_aMicroglia _ximmunology |
| 650 | 0 | 4 |
_aOncolytic Virotherapy _xmethods |
| 650 | 0 | 4 |
_aOncolytic Viruses _xgrowth & development |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBarf, Milena | |
| 700 | 1 | _aGeletneky, Karsten | |
| 700 | 1 | _aUnterberg, Andreas | |
| 700 | 1 | _aRommelaere, Jean | |
| 773 | 0 |
_tViruses _gvol. 9 _gno. 12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/v9120382 _zAvailable from publisher's website |
| 999 |
_c27893019 _d27893019 |
||